PositoAI/ CA/ BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

Toronto: BCT · Healthcare

Positivity Index

#5,432 / 12,644

Global

#473 / 1,768

Canada

Positivity Score

21,641

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

BriaCell Therapeutics Corp. — Overview & Financial Snapshot

BriaCell Therapeutics Corp. (Toronto: BCT) is a Healthcare company, ranked #5,432 of 12,644 companies globally and #473 of 1,768 in Canada on PositoAI, with a Positivity Score of 21,641. Its market capitalisation is ₹296.21 Cr (C$43.59M), P/E ratio is -3.9 and P/B ratio is 1.29. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#21 Organigram Global Inc. 25,113 #25 Quest PharmaTech Inc. 24,859 #45 Vaxil Bio Ltd. 24,515 #89 Cipher Pharmaceuticals Inc. 23,939 #138 CanadaBis Capital Inc 23,370

— Nothing to show —

OpenAI is reading recent news...

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

P/B Ratio 1.29

P/E Ratio -3.9

D/E Ratio 0.00

ROE -175.25%

Owes vs Owns ? —Not available

Dividend Yield 0.00%

Trailing EPS ₹-86.31C$-1.27

Forward EPS ₹-36.70C$-0.54

Beta 1.51

Market Cap ₹296.21 CrC$43.59M

What these numbers mean →

What does BriaCell Therapeutics Corp. do?

What is BriaCell Therapeutics Corp.'s P/E and P/B ratio?

BriaCell Therapeutics Corp. has a P/E ratio of -3.9 and a P/B ratio of 1.29.

What is BriaCell Therapeutics Corp.'s debt-to-equity ratio?

BriaCell Therapeutics Corp. has a debt-to-equity ratio of 0.00.

What is BriaCell Therapeutics Corp.'s Positivity rank?

BriaCell Therapeutics Corp. is ranked #5,432 of 12,644 companies globally and #473 of 1,768 in Canada on PositoAI, with a Positivity Score of 21,641.

Does BriaCell Therapeutics Corp. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BriaCell Therapeutics Corp..

Where can I read the latest news about BriaCell Therapeutics Corp.?

Recent headlines about BriaCell Therapeutics Corp. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does BriaCell Therapeutics Corp. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of BriaCell Therapeutics Corp.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.